ASH Clinical News September 2015 | Page 37

CLINICAL NEWS ABIM Clarifies Board Certification and Enrollment in MOC Status The American Board of Internal Medicine (ABIM) has announced a change to its controversial maintenance of certification (MOC) rules. Following a revision of the MOC program in January 2014 that attempted to simplify the fee structure by adding an annual payment option as an alternative to the 10-year fee, the organization was met with criticism charging that for physicians who did not enroll in and pay for the program in years in which they did not have to complete any requirements, they became labeled not certified as a result of this change. According to a blog post from Richard Baron, MD, the president and CEO of ABIM, “This policy had a particular adverse effect on those who just completed training or were engaged in fellowship. That did not seem right to me, to our board, or to many other members of the internal medicine community.” The organization announced it now permits physicians who have met the other program requirements to keep their certification if they do not enroll in the MOC program during a particular year. Physicians will still need to be current with payments and meet ongoing program requirements, and internists must still meet five- and 10-year program milestones to maintain certification. The MOC program has come under fire over the past year for its requirements, fees, and content. ● Source: ABIM news release, August 4, 2015. T:7” Males Lenalidomide is present in the semen of males who take REVLIMID. Therefore, males must always use a latex or synthetic condom during any sexual contact with females of reproductive potential while taking REVLIMID, during dose interruptions and for up to 28 days after discontinuing REVLIMID, even if they have undergone a successful vasectomy. Male patients taking REVLIMID must not donate sperm 8.7 Renal Impairment Since lenalidomide is primarily excreted uncha